Ordering
Available Variants5 mg
CHA.39556-5mg
Price
€223.20
Available – Dispatch in 14 days
25 mg
CHA.39556-25mg
Price
€407.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.39556-5mg | €223.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.39556-25mg | €407.20 |
powder, ≥95% (TLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 6090-95-5 |
|---|---|
| UNSPSC Code | 12352119 |
| PubChem Substance ID | 24892783 |
| NACRES | NA.32 |
| MDL number | MFCD00077326 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Conduritol B epoxide, with the CAS registry number 6090-95-5, is a chemical compound that has been utilized in various biochemical and pharmacological studies. It is an epoxide derivative of conduritol, a cyclitol that is known for its inhibitory effects on certain enzymes. Conduritol B epoxide has been employed as a specific inhibitor of beta-glucosidase, an enzyme involved in the breakdown of glycosidic bonds. The compounds mechanism of action involves the formation of a covalent bond with the enzyme, resulting in its irreversible inactivation. This property makes Conduritol B epoxide a valuable tool for investigating the biological functions of beta-glucosidase and its role in various diseases, including lysosomal storage disorders. Its use has contributed significantly to the understanding of glycosidase enzymes and their potential as therapeutic targets.
